Growth PotentialThe Cancer Dx program will offer affordable oncology testing for common canine cancers, boosting future growth potential.
InnovationIDEXX maintained its +10% long-term growth target, supported by innovation and expanded diagnostic utilization.
Market LeadershipIDXX is the dominant global market leader in animal health diagnostics and has a particularly strong and deep management team, broad portfolio of market-leading products, and a strong operational track record for execution and innovation.